JP2022027513A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022027513A5 JP2022027513A5 JP2021112822A JP2021112822A JP2022027513A5 JP 2022027513 A5 JP2022027513 A5 JP 2022027513A5 JP 2021112822 A JP2021112822 A JP 2021112822A JP 2021112822 A JP2021112822 A JP 2021112822A JP 2022027513 A5 JP2022027513 A5 JP 2022027513A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- peptide
- acid sequence
- epea
- eeg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020127958 | 2020-07-29 | ||
| JP2020127958 | 2020-07-29 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022027513A JP2022027513A (ja) | 2022-02-10 |
| JP2022027513A5 true JP2022027513A5 (https=) | 2024-07-30 |
| JP7849854B2 JP7849854B2 (ja) | 2026-04-22 |
Family
ID=80036234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021112822A Active JP7849854B2 (ja) | 2020-07-29 | 2021-07-07 | シヌクレイノパチーを予防又は治療するために使用されるペプチド |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230242601A1 (https=) |
| EP (1) | EP4190797A4 (https=) |
| JP (1) | JP7849854B2 (https=) |
| CN (1) | CN115667281A (https=) |
| WO (1) | WO2022024693A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025192147A1 (ja) * | 2024-03-15 | 2025-09-18 | 公益財団法人東京都医学総合研究所 | αシヌクレインの蓄積抑制用の組成物、及びその利用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1451217A4 (en) * | 2001-11-20 | 2005-10-12 | Atgen Co Ltd | NEW PEPTIDES PROVIDING ENVIRONMENTAL RESISTANCE, AND FUSION PROTEINS CONTAINING THOSE PEPTIDES |
| TW200509968A (en) * | 2002-11-01 | 2005-03-16 | Elan Pharm Inc | Prevention and treatment of synucleinopathic disease |
| US8506959B2 (en) * | 2002-11-01 | 2013-08-13 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
| US20050203010A1 (en) * | 2003-11-14 | 2005-09-15 | Atgen Co., Ltd. | Novel peptides conferring environmental stress resistance and fusion proteins including said peptides |
| ZA200701531B (en) * | 2004-08-09 | 2009-03-25 | Elan Pharm Inc | Prevention and treatment of synucleinopathic and amyloidogenic disease |
| PL2583978T3 (pl) * | 2007-02-23 | 2016-07-29 | Prothena Biosciences Ltd Co | Profilaktyka i leczenie chorób synukleinopatycznych i amyloidogennych |
| AT508638B1 (de) * | 2009-08-21 | 2011-08-15 | Affiris Ag | Verwendung von peptiden und polypeptiden zur behandlung und/oder prävention von synukleinopathien |
| GB201008682D0 (en) * | 2010-05-25 | 2010-07-07 | Vib Vzw | Epitope tag for affinity based applications |
| KR20120093002A (ko) * | 2011-02-14 | 2012-08-22 | (주)에이티젠 | Ｎｋ 세포의 활성 측정을 이용한 암 진단 방법 및 진단 키트 |
| LT3071597T (lt) | 2013-11-21 | 2020-10-12 | F. Hoffmann-La Roche Ag | Antikūnai prieš alfa-sunukleiną ir jų naudojimo būdai |
| US20180134775A1 (en) * | 2016-11-17 | 2018-05-17 | United Arab Emirates University | Alpha-Synuclein Antibodies (7A11) |
| CA3051839A1 (en) * | 2017-02-17 | 2018-08-23 | Bristol-Myers Squibb Company | Antibodies to alpha-synuclein and uses thereof |
| WO2018226590A1 (en) * | 2017-06-05 | 2018-12-13 | The Trustees Of Columbia University In The City Of New York | Peptides as biomarkers in the diagnosis, confirmation and treatment of a neurological disorder and immunoprofiling in neurodegenerative disease |
| WO2020181273A1 (en) * | 2019-03-06 | 2020-09-10 | Cue Biopharma, Inc. | Antigen-presenting polypeptides with chemical conjugation sites and methods of use thereof |
-
2021
- 2021-07-07 CN CN202180036867.0A patent/CN115667281A/zh active Pending
- 2021-07-07 JP JP2021112822A patent/JP7849854B2/ja active Active
- 2021-07-07 WO PCT/JP2021/025577 patent/WO2022024693A1/ja not_active Ceased
- 2021-07-07 EP EP21850367.0A patent/EP4190797A4/en active Pending
- 2021-07-07 US US17/924,461 patent/US20230242601A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024178382A5 (https=) | ||
| JP2022517442A5 (https=) | ||
| JP2009544279A5 (https=) | ||
| JP2022514687A5 (https=) | ||
| JP2022517040A5 (https=) | ||
| JPWO2019156137A5 (https=) | ||
| JP2022513223A5 (https=) | ||
| WO2001072721A3 (en) | Synergistic methods and compositions for treating cancer | |
| JP2022517399A5 (https=) | ||
| JP2023538422A5 (https=) | ||
| JP2006506942A5 (https=) | ||
| JP2018512454A5 (https=) | ||
| WO2003057721A3 (en) | Substituted amino carboxamides for the treatment of alzheimer's disease | |
| AR025307A1 (es) | Compuesto de liberacion sostenida de un peptido, microparticulas, composicion farmaceutica y el uso de dicho compuesto para la fabricacion de un medicamento | |
| JP2020500871A5 (https=) | ||
| JP2021530541A5 (https=) | ||
| JP2021514003A5 (https=) | ||
| JP2002524415A5 (https=) | ||
| GEP20043285B (en) | Sustained Release Beadlets Containing Stavudine, Method for Their Production, Pharmaceutical Composition Containing the Same and Use Thereof for Treatment Retroviral Infections | |
| JP2022027513A5 (https=) | ||
| CN110799522A (zh) | 用于治疗、改善或预防脑出血的肽及其用途 | |
| JP2022506716A5 (https=) | ||
| JP2018537987A5 (https=) | ||
| JP2007536279A5 (https=) | ||
| WO2003084979A3 (fr) | Peptides et leur application en therapeutique |